Adaptive Immunity and Parkinson's Disease

Area of Science:

• Neuroimmunology
• Immunogenetics

Background:

• Adaptive immunity, specifically T cells, is increasingly recognized for its role in Parkinson's disease (PD) pathogenesis.
• Genetic susceptibility variants and aging significantly influence T-cell dynamics and immune responses in PD.

Purpose of the Study:

• To review the involvement of CD4+ and CD8+ T cells in PD development.
• To explore the impact of genetic factors and aging on T-cell responses in PD.
• To discuss the potential for immunotherapy targeting T-cell-mediated neuroinflammation.

Main Methods:

• Literature review focusing on adaptive immunity in Parkinson's disease.
• Analysis of the interplay between genetic susceptibility, aging, and T-cell function.
• Examination of T-cell receptor repertoire and antigen presentation mechanisms.

Main Results:

• Major histocompatibility complex (MHC) association with PD affects antigen presentation and T-cell receptor repertoire, influencing susceptibility and progression.
• Aging exacerbates neuroinflammation in PD through immunosenescence, altering T-cell dynamics.
• T-cell-mediated immune responses significantly impact brain physiopathology and neurodegeneration in PD.

Conclusions:

• T-cell involvement is central to PD pathogenesis, modulated by genetics and aging.
• Targeting T-cell-mediated neuroinflammation offers potential for early immunotherapy in PD.
• Engineered regulatory T cells could provide antigen-specific immunomodulation against pathogenic proteins like alpha-synuclein.